FAQs

Frequently Asked Questions

Q. How many people can you test at an event?

Each Lookout Health mobile lab can handle between 25 and 30 tests per hour. For larger events, Lookout Health can provide multiple mobile labs.

Q. How accurate are your tests?

Lookout Health uses the latest rapid testing technology available at the time of service.  The accuracy of each test will depend on such factors as the type of test (e.g. molecular, antigen, etc.), the timing of specimen collection (how long the individual has been infected with the virus) and the biology of the individual.  Test manufacturers report the analytic sensitivity (ability to detect a positive case) and specificity (ability to determine a negative case) based on a set of known positive and negative samples.  Lookout Health will share this data with our clients based on the specific test to be used at their event.

Q. Do you test symptomatic patients?

No, we request that each event organizer ask any individuals that show signs of infection of any contagious disease, including COVID-19, to remain at home and not risk infecting others.

Q. How quickly are test results provided?

We are generally able to provide test results within 15 minutes from the time the sample is taken.

Q. How are samples taken?

For our current testing technology, we collect samples using a nasal swab rubbed on the inside wall of both nostrils.  We do not use the more invasive nasopharyngeal swabs. We continue to evaluate other testing technologies as they are developed and authorized by the FDA, including some that use saliva, breath and other methods of sample collection. 

Q. Do you test for COVID-19 antibodies?

Yes. The COVID-19 antibody test is a blood test that detects whether a person had the COVID-19 virus in the past and at that time developed antibodies to the virus.  The antibody test does not indicate whether an individual is currently infected or contagious with COVID-19.  The antibody test may indicate whether a person has developed some level of immunity to COVID-19, although this remains a subject of scientific research.